Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Santarelli

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 20, 2014
A randomized, placebo-controlled study investigating the nicotinic α7 agonist, RG3487, for cognitive deficits in schizophreniaDaniel Umbricht, Richard S E Keefe, Stephen Murray, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 5, 2006
Neurokinin 1 receptor antagonism requires norepinephrine to increase serotonin functionGabriella Gobbi, Tommaso Cassano, Fatiha Radja, et al.
Nature|March 29, 2002
Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adultCornelius Gross, Xiaoxi Zhuang, Kimberly Stark, et al.
IEEE Transactions on Bio-Medical Engineering|July 11, 2018
Evaluation of an Integrated System of Wearable Physiological Sensors for Stress Monitoring in Working Environments by Using Biological MarkersStefano Betti, Raffaele Molino Lova, Erika Rovini, et al.
JAMA Psychiatry|June 16, 2016
Efficacy and Safety of Basimglurant as Adjunctive Therapy for Major Depression: A Randomized Clinical TrialJorge A Quiroz, Paul Tamburri, Dennis Deptula, et al.
Neuropharmacology|April 5, 2011
Enhanced long-term depression and impaired reversal learning in phosphodiesterase 4B-knockout (PDE4B-/-) miceKris Rutten, Tanya L Wallace, Melissa Works, et al.
Plos One|December 28, 2020
In vitro and in vivo characterization of Recifercept, a soluble fibroblast growth factor receptor 3, as treatment for achondroplasiaDiogo Gonçalves, Guylène Rignol, Pierre Dellugat, et al.
Nature Neuroscience|May 2, 2006
Hippocampal neurogenesis is not required for behavioral effects of environmental enrichmentDar Meshi, Michael R Drew, Michael Saxe, et al.
Schizophrenia Research|August 11, 2014
Circadian rhythms in cognitive functioning among patients with schizophrenia: impact on signal detection in clinical trials of potential pro-cognitive therapiesMichael R Hufford, Vicki G Davis, Dana Hilt, et al.
The American Journal of Gastroenterology|November 12, 2002
Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled studyFilippo Cremonini, Simona Di Caro, Marcello Covino, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 20, 2014
A randomized, placebo-controlled study investigating the nicotinic α7 agonist, RG3487, for cognitive deficits in schizophreniaDaniel Umbricht, Richard S E Keefe, Stephen Murray, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 5, 2006
Neurokinin 1 receptor antagonism requires norepinephrine to increase serotonin functionGabriella Gobbi, Tommaso Cassano, Fatiha Radja, et al.
Nature|March 29, 2002
Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adultCornelius Gross, Xiaoxi Zhuang, Kimberly Stark, et al.
IEEE Transactions on Bio-Medical Engineering|July 11, 2018
Evaluation of an Integrated System of Wearable Physiological Sensors for Stress Monitoring in Working Environments by Using Biological MarkersStefano Betti, Raffaele Molino Lova, Erika Rovini, et al.
JAMA Psychiatry|June 16, 2016
Efficacy and Safety of Basimglurant as Adjunctive Therapy for Major Depression: A Randomized Clinical TrialJorge A Quiroz, Paul Tamburri, Dennis Deptula, et al.
Neuropharmacology|April 5, 2011
Enhanced long-term depression and impaired reversal learning in phosphodiesterase 4B-knockout (PDE4B-/-) miceKris Rutten, Tanya L Wallace, Melissa Works, et al.
Plos One|December 28, 2020
In vitro and in vivo characterization of Recifercept, a soluble fibroblast growth factor receptor 3, as treatment for achondroplasiaDiogo Gonçalves, Guylène Rignol, Pierre Dellugat, et al.
Nature Neuroscience|May 2, 2006
Hippocampal neurogenesis is not required for behavioral effects of environmental enrichmentDar Meshi, Michael R Drew, Michael Saxe, et al.
Schizophrenia Research|August 11, 2014
Circadian rhythms in cognitive functioning among patients with schizophrenia: impact on signal detection in clinical trials of potential pro-cognitive therapiesMichael R Hufford, Vicki G Davis, Dana Hilt, et al.
The American Journal of Gastroenterology|November 12, 2002
Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled studyFilippo Cremonini, Simona Di Caro, Marcello Covino, et al.
Pageof 5